EurekaBio

Series-B+
eurekabio.com Biotech & Healthcare
Total Funding $40M
Latest Round $40M Series-B+
Last Announced Mar 7, 2024
Investors Undisclosed
Decision Makers 3 Verified

About EurekaBio

EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website eurekabio.com
Domain Registered Date Nov 12, 2013

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $40,000,000 · Series-B+

    startupintros.com

  2. Milestone

    Website domain registered

    eurekabio.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for EurekaBio.

Funding History

1 Round
Series-B+ · Mar 7, 2024

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts